Back to Trades
McKenna Mark C.
InsiderCIK 0001749623
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 6
- Active
- 2025–2026
McKenna Mark C. has filed 7 SEC reports (2025–2026), spread across 6 companies, totaling $6.5M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Oct 20 | TCXB TCGX Acquisition Corp. II | McKenna Mark C. | Insider | Other | $0 |
| Sep 3 | APGE Apogee Therapeutics, Inc. | McKenna Mark C. | Insider | Disposed | $5.2M |
| Jul 22 | FRNM Freenome, Inc. | McKenna Mark C. | Insider | Conversion | $0 |
| Jun 11 | APGE Apogee Therapeutics, Inc. | McKenna Mark C. | Director | Award | $650.8K |
| May 29 | SYRE Spyre Therapeutics, Inc. | McKenna Mark C. | Director | Award | $582.0K |
| Jan 22 | HLXC Helix Acquisition Corp. III | McKenna Mark C. | Director | Other | $0 |
| Aug 11 | BBOT BridgeBio Oncology Therapeutics, Inc. | McKenna Mark C. | Insider | Exercise | $0 |
7 filings